Laboratory mice bearing inactivating mutations in the genes encoding the NPAS1 and NPAS3 transcription factors have been shown to exhibit a spectrum of behavioral and neurochemical abnormalities. Behavioral abnormalities included diminished startle response, as measured by prepulse inhibition, and impaired social recognition. NPAS1͞NPAS3-deficient mice also exhibited stereotypic darting behavior at weaning and increased locomotor activity. Immunohistochemical staining assays showed that the NPAS1 and NPAS3 proteins are expressed in inhibitory interneurons and that the viability and anatomical distribution of these neurons are unaffected by the absence of either transcription factor. Adult brain tissues from NPAS3-and NPAS1͞NPAS3-deficient mice exhibited a distinct reduction in reelin, a large, secreted protein whose expression has been reported to be attenuated in the postmortem brain tissue of patients with schizophrenia. These observations raise the possibility that a regulatory program controlled in inhibitory interneurons by the NPAS1 and NPAS3 transcription factors may be either substantively or tangentially relevant to psychosis.
M
ice, humans, and other vertebrates contain genes encoding two related transcription factors designated neuronal PAS domain protein 1 (NPAS1) and NPAS3 (1, 2) . The two proteins are members of the basic helix-loop-helix (bHLH)-PAS domain family of transcription factors. Members of this family respond to various environmental stimuli, including light, oxygen, voltage, and redox potential (3) (4) (5) . NPAS1 and NPAS3 are highly related in primary amino acid sequence and indistinguishable when tested by a variety of functional assays. One notable difference between NPAS1 and NPAS3 is the size of their encoding genes. The 11 exons of the NPAS1 gene are housed within a 20-kb segment of mouse chromosome 7 (human chromosome 19) . By contrast, the equivalent exons of the NPAS3 gene span 791 kb of mouse chromosome 12 (human chromosome 14) .
A disruption in the human NPAS3 gene has recently been reported in a family suffering from schizophrenia (6) . A translocation between chromosomes 9 and 14 results in truncation of the NPAS3 gene between exons 2 and 3. If expressed, the protein product of the disrupted NPAS3 locus can be predicted to contain an intact bHLH DNA-binding domain missing both PAS domains and all amino acids C-terminal to the PAS domains. Affected mother and daughter are reported to carry the t(9;14) (q34;q13) translocation, whereas the unaffected father does not.
NPAS1-, NPAS3-, and doubly deficient mouse strains have been prepared by targeted gene disruption. Behavioral studies of these mice reveal distinctive abnormalities, including impaired startle response, diminished social recognition, stereotypic darting behavior, and enhanced locomotor activity. Immunohistochemical staining assays of CNS tissues further reveal attenuation in the expression of reelin in NPAS3-and NPAS3͞NPAS1-deficient mice. We hereby hypothesize that these transcription factors will control regulatory pathways that may possibly be relevant to the etiology of psychosis.
Methods
Approval for the animal experiments described herein was obtained by the University of Texas Southwestern Medical Center Institutional Animal Care and Use Committee. A full description of methods for the targeting of the NPAS1 and NPAS3 genes can be found in Supporting Text, which is published as supporting information on the PNAS web site. males (F 1 ) produced 129͞SvEv:C57BL͞6J mixed strain litters. Healthy pups were ear-tagged and tail-snipped when weaned (21 days). Pups that displayed growth deficiencies were group-housed and received special care (nesting squares, isolation foam under the cage, and 11% soaked food) until viable. Eventually all animals were group-housed until time of testing. Genotypes for the NPAS1 and NPAS3 loci were established by PCR analysis.
tocol by using the Vector Elite kit (Vector Laboratories) with a biotinylated anti-rabbit IgG. The final horseradish peroxidase reaction product was developed with the Vector DAB peroxidase substrate kit. Sections were floated onto subbed slides, allowed to air dry, dipped in Histoclear, and coverslipped with Permount. Sections were viewed with a Nikon Eclipse E1000M microscope equipped with a DMX1200F digital camera. Images were acquired with ACT-1 software. Contrast adjustments of the digital images were made by using PHOTOSHOP (Adobe Systems, San Jose, CA). A more complete description of the immunocytochemical protocol, details of antibody generation, sources, and dilutions of other antibodies examined can be found in Supporting Text.
Measurement of Reelin Expression. Mice of the following genotypes were perfused as described above: NPAS1
(n ϭ 5). The brains were sectioned from the preoptic area to the midbrain and processed through the immunocytochemical protocol described above, except that the Vector Elite Mouse IgG kit was used. To reduce background staining, the Vector MOM kit was used according to the manufacturer's instructions. Sections were examined on a Zeiss IIIRS microscope equipped with a Polaroid digital camera. Reelin-positive neurons were counted at a final magnification of ϫ125 from five sections of each brain. The anatomical areas examined for reelin immunoreactivity were as follows: cingulate cortex, a field encompassing the junction of the primary motor cortex and the somatosenory cortex, the dentate gyrus of the hippocampus, piriform cortex, and medial amygdala. Reelinpositive cells were counted on one side of the brain by an experimenter blind to genotype. The cell counts for each area were compared by a matched-pair t test.
Results
Anatomical Expression Profiles of NPAS1 and NPAS3. Two methods were used to define the distribution of NPAS1 expression in the adult mouse brain. The targeting construct used to disrupt the NPAS1 gene placed the ␤-galactosidase gene of Escherichia coli in frame with the N-terminal 41 aa of the truncated NPAS1 polypeptide. Coronally sectioned material from wild-type (wt) mice, NPAS1 heterozygotes and NPAS1 homozygotes were stained for ␤-galactosidase according to a protocol contained in Supporting Text. Intensely stained ␤-galactosidase-positive cells were observed in the dentate gyrus of NPAS1 homozygotes (Fig.  1A) . Similarly distributed but less intense staining was observed in NPAS1 heterozygotes and no discernable staining was observed in the brain tissue of wt mice. That this ␤-galactosidasestaining pattern recapitulates the bona fide expression pattern of the NPAS1 gene was confirmed by use of antibodies prepared against the recombinantly expressed NPAS1 protein. NPAS1-specific antibodies stain the nuclear compartment of the same cell population observed to express ␤-galactosidase in NPAS1 homozygotes and heterozygotes (Fig. 1B) . Given that antibody staining was eliminated in NPAS1 homozygotes and diminished in NPAS1 heterozygotes (relative to tissue derived from wt animals), we conclude that both the antibody-and ␤-galactosidase-staining patterns accurately reveal the pattern of NPAS1 gene expression in the adult mouse brain.
NPAS1 is expressed in a relatively small number of cells distributed throughout the brain (Fig. 5A , which is published as supporting information on the PNAS web site). Sites of expression include the hippocampus, dentate gyrus, piriform cortex, medial septum, and cortical layers 1, 4, and 5. The specific cells expressing NPAS1 were relatively small compared with the large, excitatory pyramidal neurons in the cortex, indicating that the protein might be expressed in inhibitory interneurons. Doublelabeling experiments were used to define the types of cells expressing NPAS1. Almost all NPAS1-positive cells costained with ␥-aminobutyric acid (GABA) or glutamic acid decarboxylase 67 (GAD-67) ( Fig. 2A) . Additionally, many NPAS1-positive cells also expressed calretinin (Fig. 6 , which is published as supporting information on the PNAS web site). In the hippocampus, the majority of calretinin-expressing neurons are GABAergic inhibitory interneurons (7, 8) . Taken together, these observations provide evidence that the NPAS1 gene is expressed primarily in inhibitory interneurons.
The targeting construct used to disrupt the NPAS3 gene did not mark the gene with ␤-galactosidase. We instead relied solely on the use of antibodies prepared against the recombinant NPAS3 protein to define its sites of expression in the adult mouse brain. NPAS3 immunoreactivity was again observed in small cells widely distributed throughout the CNS. Antibody staining was restricted to the nuclear compartment of sectioned material from wt mice (Fig. 1C ), yet it was totally absent from NPAS3 homozygotes (Fig. 1D ). The number of NPAS3-positive cells exceeded NPAS1-positive cells by at least an order of magnitude, and staining was observed in a fairly uniform manner throughout the brain (Fig. 5B) . Costaining assays revealed no overlap with the glial fibrillary acidic protein marker for astroglial cells (Fig.  7 , which is published as supporting information on the PNAS web site), yet almost perfect concordance with GABA (Fig. 2B) . Some NPAS3-expressing neurons were also calretinin-positive ( Fig. 8 , which is published as supporting information on the PNAS web site). We therefore conclude that both the NPAS1 and NPAS3 transcription factors are primarily expressed in inhibitory interneurons of the adult mouse brain.
Behavioral Deficits in NPAS1, NPAS3, and NPAS1/NPAS3 Mutant Mice.
Among the eight genotypes under study, informative differences in behavioral and physiological parameters could be deduced from analyses of a subset of only four, NPAS1 Ϫ/Ϫ :NPAS3
(NPAS3 homozygote), and NPAS1 ϩ/ϩ :NPAS3 ϩ/ϩ (wt). Heterozygosity of either locus compounded over homozygosity of the paralogous locus did reveal phenotypic trends consistent with deficits revealed by the four genotypes listed above. However, in no case did such data achieve statistical significance.
Upon weaning into groups of 5 or more it was observed that a small number of animals displayed an abnormal, stereotypic darting behavior. An example can be viewed in Movie 1, which is published as supporting information on the PNAS web site. Of the 89 mice that were systematically observed, only four exhibited this behavior. All four mice were homozygous null at the NPAS3 locus and either homozygous null or heterozygous at the NPAS1 locus. Of the remaining 85 mice, none were homozygous null at the NPAS3 locus. Therefore, this stereotypic locomotor activity was exclusively dependent on the absence of NPAS3.
With respect to the general health and behavioral parameters measured at 4 months of age, no genotype-dependent differences were observed regarding body temperature, eye-blink response, ear-twitch response, whisker orientation, hearing, smell, or grip strength (Table 1 , which is published as supporting information on the PNAS web site). Additionally, no differences were observed in longevity among the four genotypes. Both sexes of NPAS1 ϩ/ϩ :NPAS3 Ϫ/Ϫ and compound nulls were Ϸ20% smaller than wt and NPAS1 Ϫ/Ϫ :NPAS3 ϩ/ϩ animals. Animals of the former two genotypes also went limp upon tail suspension, displayed a shorter and irregular stride length indicative of a slightly abnormal gait, and were slightly uncoordinated on early rotarod trails. As with wt and NPAS1 homozygotes, however, NPAS3 homozygotes and double-null animals were able to learn effective motor coordination upon repeated rotarod testing. No genotype-dependent differences were detected in the hanging wire test, the rotarod test, the test for anosmia, or the shockthreshold test (data not shown). A genotype-dependent difference was observed in the cued learning task. Instead of freezing in response to a conditioning stimulus previously coupled with a mild foot shock, NPAS1:NPAS3 double-null animals exhibited an enhanced level of motion in this behavioral assay (Fig. 9 , which is published as supporting information on the PNAS web site). Finally, females of all genotypes were fertile, yet the NPAS1 ϩ/ϩ :NPAS3 Impaired Prepulse Inhibition. Initially, mice of all four genotypes were tested for startle responses to sound stimuli ranging from 70 dB (background noise) to 120 dB. No genotype-dependent differences in hearing ability were observed (Fig. 10 , which is published as supporting information on the PNAS web site). For the prepulse inhibition test, mice were first assessed for acoustic startle response to 40 msec of a 120-dB pulse in the presence of the 70-dB background. Mice of all genotypes responded equivalently to this baseline startle pulse. Prepulse inhibition was then measured by applying prepulses of 78 or 86 dB followed by the 120-dB startle pulse. A statistically significant reduction in prepulse inhibition was observed in NPAS1 and wt mice (Fig. 3A) . NPAS1 ϩ/ϩ :NPAS3 Ϫ/Ϫ mice appeared to be attenuated in prepulse inhibition at both the 78-and 86-dB prepulse sound levels, yet in neither case did such data achieve statistical significance. Impaired Social Recognition. Social recognition was investigated by assessing the response of adults of varying genotypes to wt juvenile mice. On day 1, animals were allowed an initial investigation of the juveniles for 2 min. Three days later (day 4) interaction time between the same two individuals was scored. The normal response to this assay is a reduction in social interaction scored on day 4, indicating a process of learned familiarization. Deficits in this paradigm of social recognition were observed in both NPAS3 homozygotes and NPAS1:NPAS3 double-null animals. Only wt animals and NPAS1 homozygotes displayed significant social recognition (Fig. 3B) . Double-null animals interacted with juveniles for a substantially shorter amount of time on day 1 (Fig. 3B Left) . The level of interaction in the double-null animals actually increased slightly on day 4, leading to an enhanced duration of investigation as integrated between the two test days (Fig. 3B Right) . NPAS1 ϩ/ϩ :NPAS3 Ϫ/Ϫ animals also exhibited a reduced level of interaction on day 1 and failed to achieve significant social recognition. Fig. 1  A and B) . Such data strongly argue that abrogation of NPAS1 function does not eliminate survival of the neurons in which this transcription factor is normally expressed. A similar interpretation can be gleaned from immunohistochemical studies of sectioned brain tissue derived from wt and NPAS3 homozygotes. A high fraction of GAD-67-expressing neurons in the cortex of adult mice costained for the NPAS3 transcription factor (Fig.  2B) . The GAD-67 staining pattern was indistinguishable in wt and NPAS3 homozygotes (Fig. 11 , which is published as supporting information on the PNAS web site), giving indirect evidence that the neurons normally expressing NPAS3 are not only alive and present in NPAS3 homozygotes, but unimpaired in their ability to express the GAD enzyme critical for production of the inhibitory neurotransmitter, GABA.
To assess whether other regulatory proteins, enzymes, or neurotransmitters might be expressed in an enhanced or attenuated manner in NPAS1, NPAS3, or doubly deficient mice, we performed immunohistochemical staining assays on brain tissue sectioned from wt, NPAS1 Ϫ/Ϫ , NPAS3 Ϫ/Ϫ , and double-null animals. No substantive differences were observed for GAD-67, parvalbumin (see Fig. 11 ), neuropeptide Y (NPY), calbindin D-28k, calretinin, or GABA (data not shown) among animals of the four genotypes. By contrast, reelin expression was substantially attenuated in numerous brain regions of both NPAS3 homozygotes and NPAS1:NPAS3 double-null animals.
Reelin was observed most prominently in the soma of small inhibitory interneurons of wt animals and was substantially diminished in cortical brain sections of NPAS3 homozygotes and NPAS1:NPAS3 double-null animals (Fig. 4 A-D) . The pattern of attenuation of reelin staining in NPAS3 homozygotes and NPAS1:NPAS3 double-null animals was not uniform across the entire CNS. For example, clusters of reelin-positive neurons located in the piriform cortex were unaffected as a function of genotype (Fig. 4 E-H) . That changes in reelin expression in various regions of the mouse brain achieved, or failed to achieve, statistical significance was confirmed by quantitative measurements scored in a blinded fashion with respect to sample genotype (Fig. 4I) . Moreover, double-labeling immunocytochemical experiments revealed that reelin extensively colocalized with NPAS1-and NPAS3-expressing neurons (Fig. 12 , which is published as supporting information on the PNAS web site).
Discussion
The observations reported in this study tentatively suggest that the NPAS3 and NPAS1 transcription factors may control regulatory pathways relevant to schizophrenia. First, behavioral studies of NPAS3 homozygotes and NPAS1:NPAS3 double-null animals gave statistically significant evidence of deficits in prepulse inhibition and social recognition, as well as substantially increased open-field locomotor activity. These behavioral abnormalities in laboratory mice, as best possible for a rodent model, mimic psychosis (9) (10) (11) . As such, they may be viewed in support of the conclusions of Kamnasaran et al. (6) who discovered a mutation in the NPAS3 gene in a family suffering from schizophrenia.
It is difficult to draw direct parallels between the behavioral abnormalities observed in NPAS1-and NPAS3-deficient mice and the complex, delusional, and cognitive defects that characterize human schizophrenia. In the human family with the NPAS3 translocation, schizophrenia was transmitted as a dominant trait, and the affected patients carried one normal allele at the NPAS3 locus. One important possibility is that the human brain is more sensitive to NPAS3 haploinsufficiency than the mouse brain, particularly regarding the relatively subtle, thought-based defects in schizophrenia. It is also possible that the human translocation produces a dominant negative effect by yielding a protein having an intact DNA-binding domain but lacking the regulatory PAS domain. Finally, we cannot exclude the possibility that the human mutation produces a gain-offunction effect that somehow disrupts NPAS3 regulation.
Regardless of mechanism, the current findings suggest that schizophrenia in the affected family members described by Kamnasaran et al. (6) results from an abnormality in the widely distributed interneurons that normally express the NPAS3 protein. Further study of the behavioral deficits in the NPAS1-, NPAS3-, and doubly deficient mice should help elucidate the regulatory defects that underlie this mouse model of schizophrenia, thereby providing further clues into this important human disease.
Aside from behavioral deficits tangentially pointing toward schizophrenia, we report two additional observations supportive of the prediction that the NPAS1 and NPAS3 transcription factors may regulate pathways relevant to psychotic illness. First, both transcription factors are expressed in inhibitory interneurons of the adult mouse brain. The processing of complex informational input into the brain is undoubtedly guided and gated by inhibitory interneurons. As such, changes in perception and inferential thinking diagnostic of schizophrenia can logically be predicted to be affected in patients suffering deficits in the function of inhibitory interneurons. Indeed, it is almost certainly the case that prepulse inhibition depends on proper function of inhibitory circuitry in the CNS (12) . Because both NPAS1 and NPAS3 are expressed in inhibitory interneurons, we speculate that they serve to control regulatory pathways important to the function of this class of neurons.
Second, among numerous markers of inhibitory interneurons sampled in this study, the sole gene product thus far observed to be affected in NPAS3 homozygotes and NPAS1:NPAS3 doublenull animals was reelin. Reelin expression was attenuated in the cortex, dentate gyrus, and amygdala of NPAS3 homozygotes and NPAS1:NPAS3 double-null mice. During embryonic patterning of the brain, reelin plays a critical role in the guidance of newborn neurons to proper cortical layers (13) . In the adult, reelin is found in a subset of GABAergic interneurons (14) , where it may act to modulate synaptic plasticity by serving as an intercellular signaling molecule (15) , as an extracellular protease (16), or both. More relevant to the present results is the report that functional and neurochemical deficits in the reeler heterozygous mice are similar to those observed in schizophrenia (17) .
The fact that reelin expression was reduced in widespread regions of the adult brain in NPAS3 homozygotes and NPAS1:NPAS3 double-null animals is consistent with numerous reports indicating an attenuation in reelin protein and mRNA in postmortem brain tissue of patients with schizophrenia (18) . In a multivariate analysis of data from the Stanley Foundation Neuropathology Consortium involving 14 different laboratories that evaluated postmortem, prefrontal brain tissue of patients with schizophrenia, a reduction in reelin mRNA emerged as the single most statistically significant variable identified in the entire study (19) . This same study identified abnormalities in cortical interneurons as one of the principal deficits in postmortem brain tissue of individuals with schizophrenia. These correlative observations articulate the challenge of understanding the functional role of reelin in the adult and the relationship of its expression to the function of the NPAS1 and NPAS3 transcription factors.
In conclusion, we tentatively identify the regulatory pathways controlled by the NPAS1 and NPAS3 transcription factors as being selectively relevant to psychotic disease. If correct, it is predictable that studies focused on the signals that activate NPAS1 and NPAS3, and the regulatory pathways downstream of these transcription factors, may provide valuable footing for the study of human psychosis. 
